drugset / Trial / NCT05013567

Efficacy and Safety Study of Ibuprofen Gel Compared to Placebo in the Treatment of Acute Musculoskeletal Pain

NCT05013567

Phase 3 Unknown 300 enrolled Brainfarma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Phase III clinical trial, multicentre of superiority, randomized, double-blind, parallel groups, placebo-controlled and use of ibuprofen gel in the treatment of acute pain.

Timeline

Start
2022-08
Primary completion
2023-05
Completion
2023-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 5 % Topical